EU ban The EU banned
estradiol,
progesterone,
testosterone,
zeranol,
melengestrol acetate and
trenbolone acetate. The first three are synthetic versions of
endogenous hormones that are naturally produced in humans and animals, and in a wide range of foods, whereas the last two are synthetic, designed to mimic the behaviour of endogenous hormones. Zeranol (alpha-zearalanol) is produced semi-synthetically, but occurs naturally in some foods. It is one of several derivatives of
zearalenone produced by certain
Fusarium. Although its occurrence in animal products can be partly due to ingestion of such feeds, alpha-zearalanol can be produced endogenously in ruminants that have ingested zearalenone and some zearalenone derivatives. The EU did not impose an absolute ban. Under veterinary supervision, cattle farmers were permitted to administer the synthetic versions of natural hormones for cost-reduction and possibly therapeutic purposes, such as synchronising
oestrus cycles. All six hormones were licensed for use in the US and in Canada. Under the
Agreement on the Application of Sanitary and Phytosanitary Measures, signatories have the right to impose restrictions on health and safety grounds subject to scientific analysis. The heart of the dispute was the fact that
risk analysis is statistical, and thus unable to determine with absolute certainty the absence of health risks. While US and Canada beef producers claimed that beef produced with the use of hormones was safe, the EU asserted that it was not safe. Little or no scientific evidence supported these restrictions. However, consumer groups successfully influenced the
European Parliament to enact regulations in the 1980s, and influenced public perceptions. In the US at the time,
consumer organizations evinced little interest prior to the 1980s, and regulations were driven by a coalition of export-oriented industry and farming interests, opposed only by organic farming groups.
EU risk assessments In 2002 the EU Scientific Committee on Veterinary Measures relating to Public Health (SCVPH) claimed that the use of beef growth hormones posed a potential health risk, and in 2003 the EU enacted Directive 2003/74/EC to amend its ban, but the US and Canada objected that the EU had not met WTO standards for scientific risk assessment. The EC claimed that the hormones remain in the tissue, specifically
17-beta estradiol. However, the EC found no clear link to health risks in humans for the other five hormones. The EC reported that high amounts of hormones had been found in areas around dense cattle lots. This increase in hormones in groundwater affected waterways and nearby wild fish. and in August 2019 they agreed to establish an initial duty-free
tariff-rate quota of tonnes annually, growing in phases over seven years to tonnes (valued at approximately US$420 million) of the EU tonnes quota of non-hormone treated beef. == Effects upon EU policy ==